84 related articles for article (PubMed ID: 15315529)
1. Cerebrospinal fluid glutamate levels in chronic migraine.
Peres MF; Zukerman E; Senne Soares CA; Alonso EO; Santos BF; Faulhaber MH
Cephalalgia; 2004 Sep; 24(9):735-9. PubMed ID: 15315529
[TBL] [Abstract][Full Text] [Related]
2. Impact of migraine on fibromyalgia symptoms.
Giamberardino MA; Affaitati G; Martelletti P; Tana C; Negro A; Lapenna D; Curto M; Schiavone C; Stellin L; Cipollone F; Costantini R
J Headache Pain; 2015; 17():28. PubMed ID: 27002510
[TBL] [Abstract][Full Text] [Related]
3. Relationship of migraine and other forms of chronic pain.
Ray JC; Matharu M; Hutton E
Handb Clin Neurol; 2024; 199():517-524. PubMed ID: 38307668
[TBL] [Abstract][Full Text] [Related]
4. Effective prophylactic treatments of migraine lower plasma glutamate levels.
Ferrari A; Spaccapelo L; Pinetti D; Tacchi R; Bertolini A
Cephalalgia; 2009 Apr; 29(4):423-9. PubMed ID: 19170689
[TBL] [Abstract][Full Text] [Related]
5. Sensitization, glutamate, and the link between migraine and fibromyalgia.
Sarchielli P; Di Filippo M; Nardi K; Calabresi P
Curr Pain Headache Rep; 2007 Oct; 11(5):343-51. PubMed ID: 17894924
[TBL] [Abstract][Full Text] [Related]
6. Alleviation of migraine related pain and anxiety by inhibiting calcium-stimulating AC1-dependent CGRP in the insula of adult rats.
Li Y; Li C; Chen QY; Hao S; Mao J; Zhang W; Han X; Dong Z; Liu R; Tang W; Zhuo M; Yu S; Liu Y
J Headache Pain; 2024 May; 25(1):81. PubMed ID: 38760739
[TBL] [Abstract][Full Text] [Related]
7. Predictive Ability of Serum Amino Acid Levels to Differentiate Fibromyalgia Patients from Healthy Subjects.
Rus A; López-Sánchez JA; Martínez-Martos JM; Ramírez-Expósito MJ; Molina F; Correa-Rodríguez M; Aguilar-Ferrándiz ME
Mol Diagn Ther; 2024 Jan; 28(1):113-128. PubMed ID: 37843759
[TBL] [Abstract][Full Text] [Related]
8. Targeting Glutamate Neurotoxicity through Dietary Manipulation: Potential Treatment for Migraine.
Martami F; Holton KF
Nutrients; 2023 Sep; 15(18):. PubMed ID: 37764736
[TBL] [Abstract][Full Text] [Related]
9. Migraine Treatment: Towards New Pharmacological Targets.
Silvestro M; Iannone LF; Orologio I; Tessitore A; Tedeschi G; Geppetti P; Russo A
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569648
[TBL] [Abstract][Full Text] [Related]
10. Pain Biomarkers in Fibromyalgia Syndrome: Current Understanding and Future Directions.
Favretti M; Iannuccelli C; Di Franco M
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445618
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers of Migraine: An Integrated Evaluation of Preclinical and Clinical Findings.
Demartini C; Francavilla M; Zanaboni AM; Facchetti S; De Icco R; Martinelli D; Allena M; Greco R; Tassorelli C
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982428
[TBL] [Abstract][Full Text] [Related]
12. Nitroglycerin as a model of migraine: Clinical and preclinical review.
Sureda-Gibert P; Romero-Reyes M; Akerman S
Neurobiol Pain; 2022; 12():100105. PubMed ID: 36974065
[TBL] [Abstract][Full Text] [Related]
13. The NMDA receptor antagonists memantine and ketamine as anti-migraine agents.
Podkowa K; Czarnacki K; Borończyk A; Borończyk M; Paprocka J
Naunyn Schmiedebergs Arch Pharmacol; 2023 Jul; 396(7):1371-1398. PubMed ID: 36869904
[TBL] [Abstract][Full Text] [Related]
14. Exploring Novel Therapeutic Targets in the Common Pathogenic Factors in Migraine and Neuropathic Pain.
Tajti J; Szok D; Csáti A; Szabó Á; Tanaka M; Vécsei L
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835524
[TBL] [Abstract][Full Text] [Related]
15. Exploring the Tryptophan Metabolic Pathways in Migraine-Related Mechanisms.
Körtési T; Spekker E; Vécsei L
Cells; 2022 Nov; 11(23):. PubMed ID: 36497053
[TBL] [Abstract][Full Text] [Related]
16. Peripheral N-methyl-D-aspartate receptor activation contributes to monosodium glutamate-induced headache but not nausea behaviours in rats.
Benbow T; Teja F; Sheikhi A; Exposto FG; Svensson P; Cairns BE
Sci Rep; 2022 Aug; 12(1):13894. PubMed ID: 35974090
[TBL] [Abstract][Full Text] [Related]
17. Interictal plasma glutamate levels are elevated in individuals with episodic and chronic migraine.
Park CG; Chu MK
Sci Rep; 2022 Apr; 12(1):6921. PubMed ID: 35484312
[TBL] [Abstract][Full Text] [Related]
18. Impaired Lymphatic Drainage and Interstitial Inflammatory Stasis in Chronic Musculoskeletal and Idiopathic Pain Syndromes: Exploring a Novel Mechanism.
Tuckey B; Srbely J; Rigney G; Vythilingam M; Shah J
Front Pain Res (Lausanne); 2021; 2():691740. PubMed ID: 35295453
[TBL] [Abstract][Full Text] [Related]
19. Testing the Role of Glutamate NMDA Receptors in Peripheral Trigeminal Nociception Implicated in Migraine Pain.
Guerrero-Toro C; Koroleva K; Ermakova E; Gafurov O; Abushik P; Tavi P; Sitdikova G; Giniatullin R
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163452
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
